Molecular biological characterisation of the novel Rifampicin inactivation mechanism in Nocardioform bacteria

Simple item page
dc.contributor.authorAndersen, Susan Jean
dc.date.accessioned2017-03-08T12:19:05Z
dc.date.available2017-03-08T12:19:05Z
dc.date.issued1996
dc.description.abstractRifampicin is one of the major antibiotics used in the treatment of Mycobacterium tuberculosis. This organism causes tuberculosis. Other related nocardioform bacteria which include the Rhodococci are opportunistic pathogens in AIDS patients. These organisms cause tuberculosis-like disease and are currently treated with rifampicin and other drugs. The presence of a low level rifampicin resistance mechanism was identified in seven rhodococcal strains and five other related and unrelated bacteria. Abbreviated Abstract. Open document to view full version]
dc.description.librarianGR2017en_ZA
dc.format.extentOnline resource (227 leaves)
dc.identifier.citationAndersen, Susan Jean (1996) Molecular biological characterisation of the novel Rifampicin inactivation mechanism in Nocardioform bacteria, University of Witwatersrand, Johannesburg, <http://wiredspace.wits.ac.za/handle/10539/22180>
dc.identifier.urihttp://hdl.handle.net/10539/22180
dc.language.isoenen_ZA
dc.subject.lcshNocardia
dc.subject.lcshRifampin
dc.subject.lcshMolecular biology
dc.subject.lcshMolecular cloning
dc.subject.lcshAntitubercular agents--Research
dc.titleMolecular biological characterisation of the novel Rifampicin inactivation mechanism in Nocardioform bacteriaen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Andersen Susan Jean._Molecular biological characte.pdf
Size:
5.63 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
ETD Collection